The urinalysis market has seen considerable growth due to a variety of factors.
• The size of the urinalysis market has seen robust growth in the past few years. The market is set to expand from $3.57 billion in 2024 to $3.83 billion in 2025, maintaining a compound annual growth rate (CAGR) of 7.2%. The historical growth of this market can be linked to factors such as increased spending on healthcare, advancements in healthcare infrastructure, changes and standardization in regulations, drug inspection and forensics, as well as clinical lab procedures.
The Urinalysis market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for urinalysis is projected to witness substantial growth over the upcoming years, with predictions of reaching $5.47 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.3%.
This anticipated growth during the forecast period can be ascribed to factors such as point-of-care testing (POCT), management of chronic diseases, an aging population, preventive healthcare measures, remote monitoring, and telemedicine. Significant trends during this period are expected to include approval of innovative drugs, technological advancements, personalized medicine, and ongoing monitoring of chronic diseases.
The urinalysis market is anticipated to be driven by an increase in the geriatric population. This term refers to individuals aged 65 and older, who are more susceptible to various diseases due to reduced immunity and age-related health conditions. A rise in age augments the probability of urinary tract infections (UTI) amongst this demographic. Testing through urinalysis inspects the visual, chemical, and microscopic aspects of urine, providing results that assist in the diagnosis and treatment of a diverse range of ailments, like diabetes, kidney disease, and infections of the urogenital tract. Data from the World Health Organization, a Switzerland-based UN agency responsible for global health matters, predicts that by 2030, the world will have six individuals 60 years or older for every ten individuals. The number of people aged 60 or over will increase from 1 billion in 2020 to 1.4 billion. Moreover, by 2050, the number of people aged 60 or older is anticipated to double to reach 2.1 billion. The 80 and over group are also expected to gain an additional 426 million individuals between 2020 and 2050. Hence, the growth in the number of older adults is forecasted to continue fueling the growth of the urinalysis market.
The urinalysis market covered in this report is segmented –
1) By Test Type: Pregnancy And Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis
2) By Product: Consumables, Instruments
3) By Application: Urinary Tract infections (UTI's), Kidney Disease, Liver Disease, Diabetes, Hypertension, Other Applications
4) By End Users: Diagnostic Laboratories, Hospitals And Clinics, Home Care Settings, Research Laboratories And Institutes
Subsegments:
1) By Pregnancy And Fertility Tests: Urine Pregnancy Tests, Ovulation Prediction Tests
2) By Biochemical Urinalysis: Dipstick Tests, Reagent Strip Tests, Microalbumin Tests
3) By Sediment Urinalysis: Microscopic Examination, Chemical Analysis Of Sediment, Culture Tests
The use of technologically advanced tools is a prominent trend being seen in the urinalysis market. Major firms in this market are shifting to incorporate artificial intelligence technology into urine examination devices. For example, Olive Diagnostics, a health tech company based in Israel that provides diagnostic tools, unveiled Olive KG in February 2022. This is an AI-powered urinalysis device that offers instantaneous health warnings and early detection for disease progression. The device checks for components such as red blood cells, proteins, ketones, nitrites, pH levels, volume, pressure, color, and urine regularity, amongst others. This device is IoMT (Internet of Medical Things) compatible and can be attached to toilets, offering real-time personal data that is secured in accordance with GDPR and HIPPA regulations.
Major companies operating in the urinalysis market include:
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd.
• Cardinal Health Inc.
• Abbott Laboratories
• Danaher Corporation
• Beckman Coulter Inc.
• Sysmex Corporation
• ARKRAY Inc.
• ACON Laboratories Inc.
• Bio-Rad Laboratories Inc.
• URIT Medical Electronic Group Co Ltd.
• 77 Elektronika Kft
• Thermo Fisher Scientific Inc.
• Teco Diagnostics
• Mindray Medical International Limited
• Quidel Corporation
• Becton Dickinson and Company
• EKF Diagnostics
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Guangzhou Wondfo Biotech Co. Ltd.
• Chembio Diagnostic Systems Inc
• Immunostics Inc.
• Inova Diagnostics Inc.
• Meridian Bioscience Inc.
• Fapon Biotech Inc.
• Nanjing Norman Biological Technology Co. Ltd.
• OraSure Technologies Inc.
• Hologic Inc.
• Randox Laboratories Ltd.
• Qiagen N.V
North America was the largest region in the urinalysis market in 2024. The regions covered in the urinalysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.